key: cord-0950514-8nsesn6z authors: OBrien, E. C.; Xu, H.; Cohen, L. W.; Shenkman, E. A.; Rothman, R. L.; Forrest, C. B.; Hernandez, A. F. title: Recent changes in COVID-19 Vaccine Hesitancy among Healthcare Workers date: 2021-03-03 journal: nan DOI: 10.1101/2021.03.01.21252457 sha: 03f17ec8e897b8876a7035a295eefb460d80b726 doc_id: 950514 cord_uid: 8nsesn6z Introduction. Early COVID-19 vaccine acceptance rates suggest that up to one-third of HCWs may be vaccine-hesitant. However, it is unclear whether hesitancy among HCWs has improved with time and if there are temporal changes whether these differ by healthcare worker role. Methods. In October 2020, a brief survey was sent to all participants in the Healthcare Worker Exposure Response and Outcomes (HERO) Registry with a yes/no question regarding vaccination under emergency use authorization (EUA): "If an FDA emergency use-approved vaccine to prevent coronavirus/COVID-19 was available right now at no cost, would you agree to be vaccinated?" The poll was repeated in December 2020, with the same question sent to all registry participants. Willingness was defined as a "Yes" response, and hesitancy was defined as a "No" response. Participants were stratified into clinical care roles. Baseline demographics of survey respondents at each timepoint were compared using appropriate univariate statistics (chi-squared and t-tests). Analyses were descriptive, with frequencies and percentages reported for each category. Results. Of 4882 HERO active registry participants during September 1-October 31, 2020, 2070 (42.4%) completed the October survey, and n=1541 (31.6%) completed the December survey. 70.2% and 67.7% who were in clinical care roles, respectively. In October, 54.2% of HCWs in clinical roles said they would take an EUA-approved vaccine, which increased to 76.2% in December. The largest gain in vaccine willingness was observed among physicians, 64.0% of whom said they would take a vaccine in October, compared with 90.5% in December. Nurses were the least likely to report that they would take a vaccine in both October (46.6%) and December (66.9%). We saw no statistically significant differences in age, race/ethnicity, gender, or medical role between time points. When restricting to the 998 participants who participated at both time points, 69% were vaccine-willing at both time points; 15% were hesitant at both time points, 13% who were hesitant in October were willing in December; and 2.9% who were willing in October were hesitant in December. Conclusions. In a set of cross-sectional surveys of vaccine acceptance among healthcare workers, willingness improved substantially over 2 calendar months during which the US had a presidential election and two vaccine manufacturers released top-line Phase 3 trial results. While improved willingness was observed in all role categories, nurses reported the most vaccine hesitancy at both time points. Early COVID-19 vaccine acceptance rates suggest that up to one-third of HCWs 1 may be vaccine-hesitant. However, it is unclear whether hesitancy among HCWs has improved 2 with time and if there are temporal changes whether these differ by healthcare worker role . 3 Methods. In October 2020, a brief survey was sent to all participants in the Healthcare Worker 4 Exposure Response and Outcomes (HERO) Registry with a yes/no question regarding 5 vaccination under emergency use authorization (EUA): "If an FDA emergency use-approved 6 vaccine to prevent coronavirus/COVID-19 was available right now at no cost, would you agree 7 to be vaccinated?" The poll was repeated in December 2020, with the same question sent to all 8 registry participants. Willingness was defined as a "Yes" response, and hesitancy was defined as 9 a "No" response. Participants were stratified into clinical care roles. Baseline demographics of 10 survey respondents at each timepoint were compared using appropriate univariate statistics (chi-11 squared and t-tests). Analyses were descriptive, with frequencies and percentages reported for 12 each category. 13 HCWs in clinical roles said they would take an EUA-approved vaccine, which increased to 17 76.2% in December. The largest gain in vaccine willingness was observed among physicians, 18 64.0% of whom said they would take a vaccine in October, compared with 90.5% in December. 19 Nurses were the least likely to report that they would take a vaccine in both October (46.6%) and 20 December (66.9%). We saw no statistically significant differences in age, race/ethnicity, gender, 21 or medical role between time points. When restricting to the 998 participants who participated at 22 both time points, 69% were vaccine-willing at both time points; 15% were hesitant at both time 23 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. available right now at no cost, would you agree to be vaccinated?" 17 The poll was repeated in December 2020, with the same question sent to all registry participants. 18 Willingness was defined as a "Yes" response, and hesitancy was defined as a "No" response. 19 Participants were stratified into clinical care roles: registered nurses/licensed practical nurses 20 (RNs/LPNs); physicians; paramedics/emergency medical technicians (EMTs); physician 21 assistants/nurse practitioners (PAs/NPs); and, other health diagnosing/treating practitioners. 22 Analyses were descriptive, with frequencies and percentages reported for each category. 23 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 3, 2021. clinical roles said they would take an EUA-approved vaccine, which increased to 76.2% in 10 December (Figure 1) . The largest gain in vaccine willingness was observed among physicians, 11 64.0% of whom said they would take a vaccine in October, compared with 90.5% in December. 12 Nurses were the least likely to report that they would take a vaccine in both October (46.6%) and 13 December (66.9%). 14 We saw no statistically significant differences in age, race/ethnicity, gender, or medical 15 role between time points. When restricting to the 998 participants who participated at both time 16 points, 69% were vaccine-willing at both time points; 15% were hesitant at both time points, 17 13% who were hesitant in October were willing in December; and 2.9% who were willing in 18 October were hesitant in December. 19 20 Discussion 21 In a set of cross-sectional surveys of vaccine acceptance among healthcare workers, willingness 22 improved substantially over 2 calendar months during which the US had a presidential election 23 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 3, 2021. and two vaccine manufacturers released top-line Phase 3 trial results. While improved 1 willingness was observed in all role categories, nurses reported the most vaccine hesitancy at 2 both time points. 3 Vaccine hesitancy is a complex problem with context-and time-specific determinants. 5 4 Hesitancy exists along a continuum, with corresponding degrees of susceptibility to change. 6 Our 5 results suggest that COVID-19 vaccine willingness can change substantially with time and with 6 changes in external factors such as experience with actual vaccine administration. Despite 7 temporal improvements, hesitancy remains high among nurses. 8 Given persistently high national COVID-19 infection rates, our study highlights an urgent 9 need for targeted interventions to increase vaccine acceptance in this critical population 10 especially since healthcare workers are often the most trusted people in the community. 11 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 3, 2021. ; https://doi.org/10.1101/2021.03.01.21252457 doi: medRxiv preprint The Duke Institutional Review Board (IRB) provided ethical oversight for the study. All participants provided informed consent prior to data collection. Drs. Hernandez, O'Brien, and Forrest reports grants from PCORI, during the conduct of the study. None of these grants relate to the content of this work. Drs. O'Brien and Hernandez report grants from Pfizer to their institution. All other authors report no relevant conflicts. The statements presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of other organizations participating in, collaborating with, or funding the Patient-Centered Outcomes Research Institute (PCORI). The study was funded by PCORI through PCORI Award (COVID-19-2020-001), "HERO Registry & Trial: Healthcare Worker Exposure Response and Outcomes." . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 3, 2021. ; https://doi.org/10.1101/2021.03.01.21252457 doi: medRxiv preprint CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 3, 2021. ; https://doi.org/10.1101/2021.03.01.21252457 doi: medRxiv preprint Immunization Coverage: Key Facts COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program -United States Report of the Sage Working Group on Vaccine Hesitancy Vaccine Hesitancy, Acceptance, and Demand